NDPH
MCID: NWD001
MIFTS: 22

New Daily-Persistent Headache (NDPH)

Categories: Rare diseases

Aliases & Classifications for New Daily-Persistent Headache

MalaCards integrated aliases for New Daily-Persistent Headache:

Name: New Daily-Persistent Headache 52
New Daily Persistent Headache 71
Ndph 52

Classifications:



External Ids:

UMLS 71 C2349426

Summaries for New Daily-Persistent Headache

MalaCards based summary : New Daily-Persistent Headache, also known as new daily persistent headache, is related to headache and migraine with or without aura 1, and has symptoms including headache An important gene associated with New Daily-Persistent Headache is TNF (Tumor Necrosis Factor). The drugs Propofol and Naltrexone have been mentioned in the context of this disorder. Affiliated tissues include testes, thyroid and eye.

Wikipedia : 74 New daily persistent headache (NDPH) is a primary headache syndrome which can mimic chronic migraine and... more...

Related Diseases for New Daily-Persistent Headache

Graphical network of the top 20 diseases related to New Daily-Persistent Headache:



Diseases related to New Daily-Persistent Headache

Symptoms & Phenotypes for New Daily-Persistent Headache

UMLS symptoms related to New Daily-Persistent Headache:


headache

Drugs & Therapeutics for New Daily-Persistent Headache

Drugs for New Daily-Persistent Headache (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 19)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Propofol Approved, Investigational, Vet_approved Phase 2 2078-54-8 4943
2
Naltrexone Approved, Investigational, Vet_approved Phase 1, Phase 2 16590-41-3 5360515
3
Ethanol Approved Phase 1, Phase 2 64-17-5 702
4
Acetylcholine Approved, Investigational Phase 2 51-84-3 187
5 Hypnotics and Sedatives Phase 2
6 Anesthetics Phase 2
7 Anesthetics, General Phase 2
8 Central Nervous System Depressants Phase 2
9 Anesthetics, Intravenous Phase 2
10 Analgesics Phase 2
11 Narcotics Phase 1, Phase 2
12 Narcotic Antagonists Phase 1, Phase 2
13 abobotulinumtoxinA Phase 2
14 Neurotransmitter Agents Phase 2
15 Acetylcholine Release Inhibitors Phase 2
16 Neuromuscular Agents Phase 2
17 Cholinergic Agents Phase 2
18 Botulinum Toxins Phase 2
19 Botulinum Toxins, Type A Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 The Effect of Single-dose Propofol Injection on Pain and Quality of Life in Chronic Daily Headache: a Randomized Double-blind Controlled Trial Completed NCT00228267 Phase 2 Propofol
2 Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children Recruiting NCT03447782 Phase 1, Phase 2 Naltrexone HCl (Bulk) Powder
3 OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study Terminated NCT01920945 Phase 2 OnabotulinumtoxinA
4 A Comparison Of Subjects With New Daily Persistent Headache (NDPH) And Subjects With Transformed Migraine (TM) Completed NCT00335803
5 Do Patients With Chronic Daily Headache Have Continuous Headache or Moments of Headache Relief? Completed NCT00880425
6 SunStar Project to Explore the Chronification Process in Headache Through Functional Imaging, Deep Phenotyping, and Analysis of CSF of Blood Products Recruiting NCT03231241

Search NIH Clinical Center for New Daily-Persistent Headache

Genetic Tests for New Daily-Persistent Headache

Anatomical Context for New Daily-Persistent Headache

MalaCards organs/tissues related to New Daily-Persistent Headache:

40
Testes, Thyroid, Eye

Publications for New Daily-Persistent Headache

Articles related to New Daily-Persistent Headache:

(show top 50) (show all 182)
# Title Authors PMID Year
1
New Daily Persistent Headache Following Dengue Fever: Report of Three Cases and an Epidemiological Study. 61
31883109 2020
2
Clinical Reasoning: An underrecognized etiology of new daily persistent headache. 61
31889019 2020
3
The Day My Life Changed: A Qualitative Study of the Experiences of Patients With New Daily Persistent Headache. 61
31769513 2020
4
Other Primary Headaches: An Update. 61
31563237 2019
5
Diagnostic Testing for Migraine and Other Primary Headaches. 61
31563228 2019
6
Multiple cranial nerve blocks for the transitional treatment of chronic headaches. 61
31084198 2019
7
New Daily Persistent Headache Syndrome Secondary to Clival Metastasis Within an Osseous Hemangioma. 61
31535364 2019
8
New Daily Persistent Headache With a Thunderclap Onset. 61
31529476 2019
9
Emerging evidence of occipital nerve compression in unremitting head and neck pain. 61
31266456 2019
10
New daily persistent headache: a systematic review on an enigmatic disorder. 61
31307396 2019
11
New daily persistent headache (NDPH) triggered by a single Valsalva event: A case series. 61
30301379 2019
12
An RCVS Spectrum Disorder? New Daily Persistent Headache Starting as a Single Thunderclap Headache (3 New Cases). 61
30830966 2019
13
New Daily Persistent Headache? Comment on "Pediatric Headache and Sleep Disturbance: A Comparison of Diagnostic Groups". 61
30973198 2019
14
Tracking patients with chronic occipital headache after occipital nerve decompression surgery: A case series. 61
30217120 2019
15
Nonmigraine Headache and Facial Pain. 61
30704679 2019
16
"Klingon headache" - a case report of mimic new daily persistent headache associated to primary essential cutis verticis gyrata. 61
30993299 2019
17
New Daily Persistent Headache: a Diagnostic and Therapeutic Odyssey. 61
30888529 2019
18
Current perspectives on the development and treatment of chronic daily headache in children and adolescents. 61
30681030 2019
19
New Daily Persistent Headache and OnabotulinumtoxinA Therapy. 61
30499777 2019
20
Resolution of new daily persistent headache by a tumor necrosis factor alpha antagonist, Venlafaxine. 61
31105954 2019
21
Differences in Pediatric Headache Prescription Patterns by Diagnosis. 61
29275494 2018
22
Flunarizine in migraine-related headache prevention: results from 200 patients treated in the UK. 61
29512871 2018
23
New daily persistent headache: An evolving entity. 61
29766926 2018
24
Pediatric Headache and Sleep Disturbance: A Comparison of Diagnostic Groups. 61
29044497 2018
25
Treatment of disabling headache with greater occipital nerve injections in a large population of childhood and adolescent patients: a service evaluation. 61
29340791 2018
26
Post-Dengue New Daily Persistent Headache: Comment. 61
29124756 2017
27
Post-Dengue New Daily Persistent Headache. 61
28796302 2017
28
Psychiatric comorbidity in new daily persistent headache: A cross-sectional study. 61
28146324 2017
29
New Daily Persistent Headache: Historical Review and an Interview with Dr. Walter Vanast. 61
28488355 2017
30
Management of children and young people with headache. 61
27998893 2017
31
A Prospective Cohort Study of Outpatient Interdisciplinary Rehabilitation of Chronic Headache Patients. 61
28127753 2017
32
Ketamine Infusions for Treatment Refractory Headache. 61
28025837 2017
33
New Daily Persistent Headache Caused by a Multinodular Goiter and Headaches Associated With Thyroid Disease. 61
28025831 2017
34
Peripheral Nerve Blocks for the Treatment of Headache in Older Adults: A Retrospective Study. 61
27901275 2017
35
Characterising the premonitory stage of migraine in children: a clinic-based study of 100 patients in a specialist headache service. 61
27770403 2016
36
Patterns of Use of Peripheral Nerve Blocks and Trigger Point Injections for Pediatric Headache: Results of a Survey of the American Headache Society Pediatric and Adolescent Section. 61
27731894 2016
37
Aprepitant for the management of nausea with inpatient IV dihydroergotamine. 61
27629088 2016
38
New daily persistent headache: A lack of an association with white matter abnormalities on neuroimaging. 61
26498346 2016
39
Chronic Daily Headache and Medication Overuse Headache in First-Visit Headache Patients in Korea: A Multicenter Clinic-Based Study. 61
27449912 2016
40
New Daily Persistent Headache. 61
27432630 2016
41
Update on New Daily Persistent Headache. 61
27080086 2016
42
New Daily Persistent Headache Is Most Likely to Begin at the Start of School. 61
26733504 2016
43
A Survey of Headache Medicine Physicians on the Likeability of Headaches and Their Personal Headache History. 61
26926707 2016
44
Resolution of New Daily Persistent Headache After Osteopathic Manipulative Treatment. 61
26927912 2016
45
Patients with tension-type headaches feel stigmatized. 61
27011641 2016
46
Triggering Events and New Daily Persistent Headache: Age and Gender Differences and Insights on Pathogenesis-A Clinic-Based Study. 61
26474179 2016
47
Update of Inpatient Treatment for Refractory Chronic Daily Headache. 61
26707496 2016
48
Spontaneous Intracranial Hypotension Treated with a Targeted CT-Guided Epidural Blood Patch. 61
26981128 2016
49
P009. A case of new daily persistent headache treated with botulinum toxin type A. 61
28132269 2015
50
Connective tissue, Ehlers-Danlos syndrome(s), and head and cervical pain. 61
25655119 2015

Variations for New Daily-Persistent Headache

Expression for New Daily-Persistent Headache

Search GEO for disease gene expression data for New Daily-Persistent Headache.

Pathways for New Daily-Persistent Headache

GO Terms for New Daily-Persistent Headache

Sources for New Daily-Persistent Headache

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....